Anorectal melanoma
- PMID: 20436837
- PMCID: PMC2780244
- DOI: 10.1055/s-0029-1223844
Anorectal melanoma
Abstract
The authors review the epidemiologic, clinicopathologic, and molecular features of anorectal melanoma, and discuss the differences between this uncommon and lethal disease and the more common and curable cutaneous form. Observations regarding outcomes after surgical resection will also be discussed, as well as predictors of survival and the use of adjuvant therapies. The recent discovery that the KIT oncogene may be aberrantly activated in a subset of patients with anorectal melanoma creates a realm of possibility for the development of targeted molecular therapy. Melanoma of the anorectum is an extremely rare tumor that is often difficult to diagnose. Its surgical management is controversial, and the prognosis remains poor.
Keywords: Melanoma; adjuvant treatment; anorectal disease; molecular therapy.
Figures
References
-
- Klas J V, Rothenberger D A, Wong W D, Madoff R D. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer. 1999;85(8):1686–1693. - PubMed
-
- Chong A E, Karnell L H, Menck H R. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664–1678. - PubMed
-
- McLaughlin C C, Wu X C, Jemal A, Martin H J, Roche L M, Chen V W. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103(5):1000–1007. - PubMed
-
- Cagir B, Whiteford M H, Topham A, Rakinic J, Fry R D. Changing epidemiology of anorectal melanoma. Dis Colon Rectum. 1999;42(9):1203–1208. - PubMed
-
- Wanebo H J, Woodruff J M, Farr G H, Quan S H. Anorectal melanoma. Cancer. 1981;47(7):1891–1900. - PubMed
